receive US funding for proprietary technologies 1990 Biocon scales up its in-house research programme‚ based on a proprietary solid substrate fermentation technology‚ from pilot to plant level 1993 Biocon’s R&D and manufacturing facilities receive ISO 9001 certification from RWTUV‚ Germany 1994 Biocon establishes Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector 1996 The commercial
Premium Pharmaceutical industry Marketing Pharmacology
eSectoral Survey Pharmaceutical Industry in Egypt November 2010 Sectoral survey: Pharmaceutical Industry Index Page 1. Introduction 2. Definition 3. Regulatory framework 3.1.Regulatory body 3.2.Pricing 3.3.TRIPS 3 4 4 4. Market analysis 4.1.Market structure 4.2.Consumption 4.3.Production 4.4.Key players 7 5. Trade 5.1.Exports 5.2.Imports 5.3.Balance of trade 9 6. SWOT analysis 7. Outlook 8. Recommendations 9. Conclusion Appendix References 11 12 13 13 2
Premium Pharmacology Generic drug Food and Drug Administration
RFID in Pharmaceutical Industry In 2004‚ US Food and Drug Administration (FDA) has called for the implementation of RFID technology to track the distribution of prescription drugs in order to protect the medical supply chain from counterfeit drugs by 2007. Initially‚ California State Board of Pharmacy has mandated RFID technology but later extended implementation date until 2015. In 2007‚ Kalorama Information predicted in a report that market for RFID solutions in pharmaceutical industry would
Premium RFID Pharmacology Pharmaceutical industry
Title: The Global Pharmaceutical Industry Date: 2011 August 20 Table of content Contents Page 1. Introduction 4 2. Pestel analysis of the global pharmaceutical industries 5-6 3. Drivers for change in the future of pharmaceutical 7 4. Five forces analysis on the global pharmaceutical industry 8-10 5. Threats to a big pharmaceutical company 11 6. Conclusion 12 7. Bibliography 13 Introduction The pharmaceutical industry According
Premium Pharmaceutical industry Generic drug Barriers to entry
A REPORT ON HRM PROBLEMS‚ APPROACHES‚ AND CHALLENGES AT Square Pharmaceuticals Ltd. By Nawfal Ahmed ID: 1321719 TO Dr. Nazmul Amin Majumder Course Instructor‚ MBA 509 A Report Presented in Partial Fulfillment of the Requirements for the Degree of Masters of Business Administration INDEPENDENT UNIVERSITY‚ BANGLADESH 23rd July‚ 2013 TABLE OF CONTENT EXECUTIVE SUMMARY……………………………………………………………………...... 5 1. Introduction I. Origin of The
Premium Human resource management Pharmacy Human resources
The global pharmaceutical industry Introduction Pharmaceutical industry is the one of big revenue business in the world. There are lots of company gains a lot of profit and market share in this industry. Most of those companies were established in 19 century and early 20 century. This study explains their model development process of pharmaceutical industry‚ it details some issue like Thalidomide tragedy in 1970’s and legislation‚ then decreases the risk of side effect and protects the patient
Premium Economics Form of government Marketing
Malijan‚ Mary Erjoy D. GENEROSO PHARMACEUTICALS AND CHEMICALS‚ INC TIME CONTEXT 1978 and in 1988 - GPC engage in the contract manufacturing of pharmaceutical products for both the domestic and export markets and the Generics Bill came in. SUMMARY / ABSTRACT This case examines the management of Mr. David Genereso in the GENERESO PHARMACEUTICALS AND CHEMICALS‚ INC to become a productive and successful company. Mr. David Generoso was a philosophy graduate of a sectarian university in the
Premium Pharmaceutical drug Strategic management Philippines
A. Introduction Pfizer‚ US pharmaceutical company is one of the largest pharmaceutical companies in the world. Unfortunately‚ Pfizer faced challenges by macro-environment forces that affect their sales volume decline dramatically in 2011. PESTEL‚ Porter’s Five Forces and Industry Lift Cycle frameworks to be applied to analysis the broad macro-environment that affected Pfizer in the pharmaceutical industry. 1. PESTEL framework PESTEL (Appendix I) is classifies into six environmental influences
Premium Pharmaceutical industry Pharmacology Food and Drug Administration
Technology and Education: How do we know it is actually helping? Silvia Suchec Professor Moore ENGL 101 C April 9th‚ 2014 Abstract Through various research on today’s technological growth‚ I have come up with a few subtopics of technology in education. There is a thorough discussion about not enough research being completed on this subject; making it difficult to understand if these resources are best for our students. I also go into depth on how much money is spent on these funds to
Premium Education Educational technology Distance education
Gemünden Institute of Technology and Innovation Management Technical University of Berlin Hardenbergstr. 4 – 5‚ HAD 29‚ 10623 Berlin Tel: +49 30 314 26088 Fax: +49 30 314 26089 Email: hans.gemuenden@tim.tu-berlin.de RAGNA SEIDLER- DE ALWIS‚ Professor at the Institute of Information Science at the University of Applied Sciences in Cologne‚ Germany. EVI HARTMANN‚ PhD‚ Consultant at A.T. Kearney‚ Frankfurt‚ Germany. HANS GEORG GEMÜNDEN‚ Professor‚ Chair of the Institute of Technology and Innovation Management
Premium Innovation Knowledge management